Exploring The Biology and Function of DYNC1LI1: A Potential Drug Target and Biomarker

Target Name: DYNC1LI1

NCBI ID: G51143

DYNC1LI1

Exploring The Biology and Function of DYNC1LI1: A Potential Drug Target and Biomarker

DYNC1LI1 (also known as LIC1) is a protein that is expressed in various tissues throughout the body, including the brain, heart, and kidneys. It is a key regulator of cell growth and differentiation, and has been implicated in a number of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

The search for new drug targets and biomarkers is a critical aspect of modern medicine, and DYNC1LI1 is an attractive target due to its unique function and the potential impact it could have on various diseases. In this article, we will explore the biology and function of DYNC1LI1, as well as its potential as a drug target and biomarker.

Biology and Function

DYNC1LI1 is a member of the T-cell receptor (TCR) family, which is responsible for cell signaling and immune surveillance. It is expressed in a variety of tissues, including the brain, heart, and kidneys, and plays a key role in regulating cell growth and differentiation.

One of the most significant functions of DYNC1LI1 is its role in the regulation of T-cell development and function. T-cells are a critical component of the immune system, and play a key role in fighting off infections and diseases. DYNC1LI1 is involved in the regulation of T-cell proliferation, differentiation, and survival, and has been implicated in a number of T-cell-related diseases, including cancer and autoimmune disorders.

In addition to its role in T-cell biology, DYNC1LI1 is also involved in the regulation of cell growth and differentiation more broadly. It has been shown to play a key role in the regulation of cell cycle progression, and is involved in the delivery of nutrients and oxygen to cells in order to support their growth and division.

Potential as a Drug Target

The potential use of DYNC1LI1 as a drug target is based on its unique function and the impact it could have on various diseases. One of the main advantages of DYNC1LI1 is its small size, which makes it an attractive target for small molecule inhibitors. Additionally, DYNC1LI1 has a clear function in T-cell biology, which makes it an attractive target for drugs that target T-cell signaling pathways.

DYNC1LI1 has been shown to play a key role in the regulation of T-cell development and function, and is involved in the development and progression of a variety of T-cell-related diseases. For example, DYNC1LI1 has been shown to be involved in the development of cancer, and has been implicated in the regulation of immune responses to viruses and bacteria.

In addition to its role in T-cell biology, DYNC1LI1 is also involved in the regulation of cell growth and differentiation more broadly. It has been shown to play a key role in the regulation of cell cycle progression, and is involved in the delivery of nutrients and oxygen to cells in order to support their growth and division.

Potential as a Biomarker

DYNC1LI1 is also an attractive target for biomarkers, due to its role in the regulation of T-cell biology and its potential impact on various diseases. For example, DYNC1LI1 has been shown to be involved in the development of cancer, and has been implicated in the regulation of immune responses to viruses and bacteria.

In addition to its potential as a drug target and biomarker, DYNC1LI1 is also of interest to researchers as a potential therapeutic target for a variety of diseases. Its small size and clear function make it an attractive target for small molecule inhibitors, and its role in T-cell biology makes it an attractive target for drugs that target T-cell signaling pathways. Further research is needed to fully understand the potential of DYNC1LI1 as a drug

Protein Name: Dynein Cytoplasmic 1 Light Intermediate Chain 1

Functions: Acts as one of several non-catalytic accessory components of the cytoplasmic dynein 1 complex that are thought to be involved in linking dynein to cargos and to adapter proteins that regulate dynein function. Cytoplasmic dynein 1 acts as a motor for the intracellular retrograde motility of vesicles and organelles along microtubules. May play a role in binding dynein to membranous organelles or chromosomes. Probably involved in the microtubule-dependent transport of pericentrin. Is required for progress through the spindle assembly checkpoint. The phosphorylated form appears to be involved in the selective removal of MAD1L1 and MAD1L2 but not BUB1B from kinetochores

The "DYNC1LI1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about DYNC1LI1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets